Fetzima on SilverScript Choice (S5601-044)
levomilnacipran hydrochloride
Covered, with prior authorization required.
Tier 4 (non-preferred drug). Quantity limit of 30 per 30 days.
$179.48
Patient pays / month, after deductible
$543.87
Patient pays / month, before the $615.00 deductible
$538.43
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
FETZIMA 80 mg Capsule, Extended Release at a preferred retail pharmacy, from the plan's negotiated price of $543.87 for a month. Other covered strengths are listed below.
Prior authRequired on all 5 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 5 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| FETZIMA 120 mg Capsule, Extended Release | 4 | $179.53 | PA · 30 per 30 days |
| FETZIMA 20 mg Capsule, Extended Release | 4 | $359.26 | PA · 60 per 30 days |
| FETZIMA 40 mg Capsule, Extended Release | 4 | $358.95 | PA · 60 per 30 days |
| FETZIMA 80 mg Capsule, Extended Release | 4 | $179.48 | PA · 30 per 30 days |
| FETZIMA Kit | 4 | 33% | PA |
Verify with the plan before prescribing or filling. Member services: (866)235-5660. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5601-044